Navigation Links
DRAXIS Health Reports Fourth Quarter and Year End Results
Date:2/7/2008

----------------------------------------------------------

Total liabilities $ 16,593 $ 13,547

-------------------------------------------------------------------------

SHAREHOLDERS' EQUITY

Common stock, without par value of

unlimited shares authorized $ 79,814 $ 77,749

Additional paid-in capital 15,984 15,475

Deficit (6,576) (8,234)

Accumulated other comprehensive income 22,119 7,425

-------------------------------------------------------------------------

Total shareholders' equity 111,341 92,415

-------------------------------------------------------------------------

Total liabilities and shareholders' equity $ 127,934 $ 105,962

-------------------------------------------------------------------------

-------------------------------------------------------------------------

See the accompanying notes to the Consolidated Financial Statements.

These interim financial statements should be read in conjunction with

the annual Consolidated Financial Statements.

DRAXIS HEALTH INC.

Consolidated Statements of Changes in Equity and Comprehensive Income

(Loss)

In Accordance with U.S. GAAP

-------------------------------------------------------------------------

(in thousands of U.S. dollars except share related data)

(unaudited)

For the Three-Month Periods For the Years

Ended December 31, Ended December 31,

--------------------------- -----------------------

2007 2006 2007 2006

----------- ----------- ----------- -
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e accurate preliminary interpretation of emergency...g neuroradiologist unavailable, according to resul...center published in the December issue of the Jou...). , The accuracy of image interpretation is th...In most training programs, radiology residents pro...
(Date:11/24/2009)...swire/--EnigmaDiagnosticsLimited,thedecentraliseda...edtodayfourseniorappointmentsforitsUSandEuropeanof...identandCEOwithGregHamilton,ChiefOperatingOfficera...U.S.headquartersinSanDiego,California,theheadquart...edforassaydevelopment,R&Dandcommercialactiviti...
(Date:11/24/2009)...ewswire/--Parties,familydinners,andothergatherings...emerrimentcanchangetomiseryiffoodmakesyouorothersi...nh/20090824/FDALOGO ) ,, Typicalsymptomsoffoodb...s,whichcanstartanywherefromhourstodaysaftercontami...thatpracticingfourbasicfoodsafetymeasurescanhelppr...
(Date:11/24/2009)...PlusofMichiganhaslaunchedfournew HealthPlusSignatu...s18to64andtheirfamilieswhoarelookingtopurchaseaffo...lusSignature plansareavailableonlineat www.HealthP...althPlusservicearea.Moreinformation,includinghelpw...o1-877-562-0907. ,, "Wearepleasedtoofferanarray...
(Date:11/24/2009)...essants, benzodiazepines, review finds , ...o take antidepressants, sedatives and other psycho...lls, a new review shows. , Canadian researchers...al of 79,081 participants older than 60. The studi...ssure medicines; diuretics; beta blockers; sedativ...
Breaking Medicine News(10 mins):Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2
...more procedures to reopen arteries, study found , ... patients with blockages in the left main coronary..., often referred to as angioplasty -- may be a via...author of the study and director of interventional...
...-Joong Gan has established that patients with a hi...ht ventricle is not capable of pumping blood again...ds a longer rest phase between each pumping phase....the lungs (pulmonary hypertension), little attenti...
...oundation,s quick reaction to a recent attack by h...s of the need for Web security for some health,org...tion -- and those who,use its online forums for he...of epilepsy that causes people to,experience seizu...
... , Montreal, March 31, 2008 A team of Canadian ... responsible for a significant fraction of ALS (sp...s commonly referred to as Lou Gehrigs disease, an ...ine edition of Nature Genetics, the study on 200 h...
...arch 31, 2008 - Responding to a study published in...ded that lung transplants were harmful for childre...latest issue of Pediatric Transplantation refute t...he conclusions of the study on post-transplant sur...
...manufacturer,of the SurgiLance safety lancet, has ... Research Foundation (JDRF) to support ongoing res... celebration of the sale of its,500 millionth safe... SurgiLance safety lancets are used by them for,re...
Other Medicine News:Health News:Angioplasty Proves Reasonable Alternative to Bypass Surgery 2Health News:Epilepsy Foundation Takes Action Against Hackers 2Health News:Researchers identify a gene responsible for Lou Gehrig's disease 2Health News:Lung transplants not dangerous for children with cystic fibrosis, after all 2Health News:MediPurpose Supports Diabetes Research Effort 2
(Date:11/24/2009)...swire/--Accumetrics,Inc.,aprivately-helddevelopera...andeasy-to-usediagnosticsystemformeasuringanindivi...vix®andaspirin),announcedtodaythatTimothyI.St...tts,ChiefFinancialOfficerofAccumetrics,willbeprese...HealthCareConferencebeingheldinNewYorkCityonDecemb...
(Date:11/24/2009)...swire/--AmbitBiosciencesCorporationannouncedtodayt...,anovelsecondgenerationFLT3inhibitor,inAMLatthe51s...heldinNewOrleans,LA,December5-8,2009.Anoralpresent...eImonotherapysafetystudyinadultswithacutemyeloidle...sentedevaluatingtheeffectofAC220monotherapyandinco...
(Date:11/24/2009)...wire-Asia-FirstCall/--LotusPharmaceuticals,Inc.,(O...ngdeveloperand,producerofprescriptionsdrugsandlice...ople,sRepublicChina,todayreporteditwillexhibitatth...ldelegation. ,, Time:November26-28,2009 ,,..., TheBeijingdelegationfeaturesmorethantwentyphar...
Breaking Medicine Technology:Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2A Wound that Does Not Heal 3A Frost 26 Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System 55241 1A Wound that Does Not Heal 3A Frost 26 Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System 55241 2Healthcare Education and Clean Energy Cited as In Demand Jobs of Tomorrow 55239 1Healthcare Education and Clean Energy Cited as In Demand Jobs of Tomorrow 55239 2Healthcare Education and Clean Energy Cited as In Demand Jobs of Tomorrow 55239 3American Medical Association Launches e Book Strategy with iPublishCentral from Impelsys 55237 1American Medical Association Launches e Book Strategy with iPublishCentral from Impelsys 55237 2American Medical Association Launches e Book Strategy with iPublishCentral from Impelsys 55237 3
...lore the Effects of Eligen(R) Delivery Technology ...en, CEDAR KNOLLS, N.J., June 30 Emisphere,Techno... Novartis Pharma AG,has launched a Phase I study i... tolerability of oral PTH134, a combination of hum...ng Emisphere,s proprietary Eligen(R),technology, f...
...une 30 DURECT Corporation,(Nasdaq: DRRX ) announ...,(FDA) has granted to DURECT orphan drug designati...ssociated with post-herpetic neuralgia (PHN).,Bupi... ELADUR(TM), DURECT,s,investigational transdermal ...duct approved for PHN, under the 1983 Orphan Drug ...
Other Medicine Technology:Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH) 2ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia 2ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia 3
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: